Skip to main content

Predictive value of insulin resistance surrogates for the development of diabetes in individuals with baseline normoglycemia: findings from two independent cohort studies in China and Japan

Abstract

Background

Insulin resistance (IR) plays a crucial role in the occurrence and progression of diabetes. This study aimed to evaluate and compare the predictive value of four IR surrogates, including the triglycerides glucose (TyG) index, TyG and body mass index (TyG-BMI), triglycerides/high-density lipoprotein cholesterol (TG/HDL-C) ratio, and the metabolic score for IR (MetS-IR) for diabetes in two large cohorts.

Methods

A total of 116,661 adult participants from the China Rich Healthcare Group and 15,464 adult participants from the Japanese NAGALA cohort were included in the study. Multivariable Cox proportional hazards models were used to assess the standardized hazard ratio (HR) of the TyG index, TyG-BMI, TG/HDL-C ratio, and MetS-IR directly associated with diabetes. Receiver operating characteristic (ROC) curve and time-dependent ROC curve analysis were performed to evaluate and compare the predictive value of the four IR surrogates for diabetes.

Results

In the two independent cohorts, the average follow-up time was 3.1 years in the China cohort, with 2681(2.30%) incident cases of diabetes recorded, and 6.13 years in the Japan cohort, with 373 incident cases (2.41%) of diabetes recorded. After adjusting for potential confounding factors, we found that among the four IR surrogates, TyG-BMI and MetS-IR showed stronger associations with diabetes. The stronger associations persisted even after further stratification by age, sex, hypertension, and obese subgroups. In terms of diabetes prediction, based on ROC analysis, TyG-BMI demonstrated the highest predictive accuracy for diabetes in the Chinese population, while both TyG-BMI and MetS-IR showed the highest predictive accuracy in the Japanese population. The results of further subgroup ROC analysis confirmed the robustness of these findings. Furthermore, the time-dependent ROC results indicated that among the four IR surrogates, MetS-IR exhibited the highest accuracy in predicting future diabetes at various time intervals in the Japanese population.

Conclusion

Our findings suggest that evaluating TyG-BMI and MetS-IR as IR surrogates may be the most useful for predicting diabetes events and assessing the risk of developing diabetes in East Asian populations.

Background

Diabetes is one of the most prominent health issues globally, with high incidence and prevalence rates. It is a key risk factor contributing to increased cardiovascular disease, physical disability, and mortality rates [1,2,3]. According to the latest survey report released by the International Diabetes Federation, as of 2021, there were 536.6 million adults (aged 21–79) worldwide with diabetes, and the number is projected to further increase to 783 million by 2045, representing a 45.92% increase [4]. In addition, diabetes has a significant and growing economic impact. The reported cost of diabetes-related diseases was approximately $966 billion in 2021, and it is estimated to reach $1054 billion by 2045, exerting tremendous pressure on families and healthcare systems [4]. Given the high prevalence of diabetes and its increasing burden, early identification of effective screening strategies to identify high-risk populations is crucial for reducing diabetes incidence rates.

IR is a critical characteristic preceding the development of diabetes [5, 6], and early quantification of IR is essential for reducing the incidence of diabetes. Various methods have been established for assessing IR, including the gold standard hyperinsulinemic-euglycemic clamp test [7], non-invasive homeostasis model assessment of IR (HOMA-IR), and quantitative insulin sensitivity check index (QUICKI) [8, 9], as well as several IR surrogates that involve combining simple parameters such as the TyG index, TyG-BMI, TG/HDL-C ratio, and MetS-IR [10,11,12,13]. Taken together, each of these IR assessment methods has its own advantages. However, from an epidemiological perspective, the invasive nature and complexity of the hyperinsulinemic-euglycemic clamp test may limit its widespread use in population-based surveys [14]. The non-invasive nature of HOMA-IR and QUICKI offers certain advantages, but it is important to note that the measurement of serum insulin is not routine [15, 16], and the insulin-based assessment methods yield fewer ideal results in populations with impaired β-cell function [8]. On the other hand, most IR surrogates are combinations of simple parameters, which do not require insulin quantification and offer convenience in measurement. These notable advantages make IR surrogates more suitable for epidemiological research and clinical practice in diabetes. Recent studies have provided compelling statistical evidence demonstrating the significant advantages of insulin resistance (IR) substitutes in assessing the risk and predicting the onset of diabetes. Furthermore, an increasing number of studies are employing individual lipid and blood glucose level indicators, along with their combined values, to develop predictive models for metabolic syndrome and diabetes, as well as other IR-related diseases [13, 17,18,19,20]. However, there is limited research systematically comparing the differences among IR surrogates in diabetes prediction and risk assessment capabilities, and the author believed that identifying one or two of the most recommended IR surrogates for diabetes prediction may be very useful for clinical practice or epidemiological investigations. Therefore, the current study aimed to evaluate and compare the predictive value of four IR surrogates, namely the TyG index, TyG-BMI, TG/HDL-C ratio, and MetS-IR, for diabetes based on national health examination data from the Rich Healthcare Group and the NAGALA cohort data from Japan.

Methods

Study data and population

This study utilized data from two population-based cohorts: the Rich Healthcare Group cohort in China and the NAGALA cohort in Japan. Detailed information regarding the design and methods of these cohorts has been previously published [21, 22], and the research data has been deposited in the public database DRYAD for open access [23, 24]. In brief, both the Rich Healthcare Group cohort and the NAGALA cohort are longitudinal follow-up studies conducted among individuals undergoing routine health check-ups. The Rich Healthcare Group cohort recruited participants who underwent health examinations in 11 cities in China between 2011 and 2016, while the NAGALA cohort recruited participants who underwent health examinations at the Murakami Memorial Hospital in Japan between 1994 and 2016. Building upon previous research, the current study aimed to further investigate the predictive value of four IR surrogates, namely the TyG index, TyG-BMI, TG/HDL-C ratio, and MetS-IR, for diabetes. Figure 1 illustrates the participant selection process for this study.

Fig. 1
figure 1

Flow chart for inclusion and exclusion of study participants

Ethics approval and informed consent

The research protocol for the Rich Healthcare Group cohort has been approved by their institutional review board [21]. The NAGALA cohort also has obtained approval from the Murakami Memorial Hospital ethics committee [22]. The current study was a post-hoc analysis of data from these two cohort studies, and the research protocol was approved by the Institutional Ethics Committee of the authors' institution (Ethics Committee of Jiangxi Provincial People’s Hospital). Additionally, since the research data were anonymized, the informed consent requirement for participants was waived by the Jiangxi Provincial People’s Hospital Ethics Committee. The entire study process was conducted in accordance with the principles of the Helsinki Declaration and followed the guidelines for Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement (Additional file 3: Text S1).

Collection and measurements of baseline information

In both cohorts, the baseline information of the participants was recorded using standardized questionnaires administered by trained healthcare professionals. This information included demographic information (age, gender), clinical characteristics (height, weight, blood pressure), living habits (smoking status, drinking status), and other relevant factors. Blood pressure, height, and weight were measured indoors using standard procedures. Fasting venous blood samples were collected from the participants after at least 8 h of overnight fasting and analyzed using automated biochemical analyzers in standard laboratories to measure biochemical parameters, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), fasting plasma glucose (FPG), HDL-C, low-density lipoprotein cholesterol (LDL-C), TG, and total cholesterol (TC). Note: The LDL-C concentration in the NAGALA cohort was calculated using the Friedewald equation [25].

Calculation of IR surrogates

The four IR surrogates were calculated as follows:

TyG index = ln [TG (mg/dL) × FPG (mg/dL)/2] [10]

TyG-BMI = TyG index × BMI [11]

TG/HDL-C ratio = TG (mmol/L)/HDL-C (mmol/L) [12]

MetS-IR = Ln [(2 × FPG (mg/dL)) + TG (mg/dL)] × BMI (kg/m 2) / (Ln [HDL-C (mg/dL)]) [13]

Predefined subgroups

To explore whether the predictive value of the four IR surrogates for diabetes varied across different population subgroups, several predefined subgroups were established based on sex, age, hypertension status, and BMI, representing commonly observed phenotypes.

(i) Sex subgroups were divided into males and females based on physiological characteristics.

(ii) The obese subgroup in both the Chinese cohort and Japanese cohort was determined based on the clinical cutoff values for BMI established by the Chinese Obesity Working Group and the Japanese Diabetes Society. Participants were categorized into the obese group (Chinese cohort: BMI ≥ 28 kg/m2; Japanese cohort: BMI ≥ 25 kg/m2) and the non-obese group (Chinese cohort: BMI < 28 kg/m2; Japanese cohort: BMI < 25 kg/m2) [26,27,28].

(iii) Age subgroups: Considering that the average age of natural menopause in Asian women is around 50 years [29], and 50 years is a critical age for the development of metabolic-related diseases in both sexes [30], the cutoff point for the age subgroup in the current study was set at 50 years.

(iv) Hypertension subgroups were defined according to individuals with or without baseline hypertension. Hypertension was diagnosed as baseline measurements of systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg [31].

Definition of diabetes

In both cohorts, the diabetes status was determined based on repeated health examinations conducted annually. The diagnosis of diabetes followed the criteria outlined in the American Diabetes Association guidelines [32], which included blood glucose measurements (FPG ≥ 7.0 mmol/L or HbA1c ≥ 6.5%) during follow-up visits and other physician-diagnosed cases of diabetes.

Statistical analysis

Cox proportional hazards regression models were established to derive the HRs and 95% confidence intervals (CIs) for the associations between the four IR surrogates and diabetes. To eliminate the dimensionality and magnitude differences of the four IR surrogates in calculating HR, we standardized these surrogates using Z-scores before incorporating them into the Cox regression models. The non-normally distributed TG/HDL-C ratio was logarithmically transformed to achieve a normal distribution before Z-score standardization. Prior to the formal regression analysis, we assessed the variance inflation factor through multiple linear regression to evaluate whether collinearity existed between the four IR surrogates and other baseline variables [33]. Additionally, we used Kaplan–Meier plots and log-rank tests to verify whether the inclusion of IR surrogates alone in the model complied with the proportional hazards assumption [34].

In the regression analysis, we first used an unadjusted univariate Cox proportional hazards regression model to initially explore the association between all baseline indicators and diabetes risk; subsequently, based on the results of univariate Cox regression analysis and following the recommendations of the STROBE guidelines, three sequentially adjusted multivariable Cox regression models were established to assess the associations between four IR surrogates and diabetes risk in the entire study population, as well as separately in the Chinese or Japanese populations [35]. Model 1 adjusted for potential confounders, including sex, age, race, and height. In the subsequent adjustment strategy (Model 2), we considered the influence of SBP, DBP, and smoking status. Finally, in Model 3, we further adjusted for blood glucose parameters (FPG), lipid parameters (HDL-C and LDL-C), and liver enzyme parameters (ALT) based on Model 2. Additionally, we calculated the corresponding E-values based on the HR and 95%CI of each IR surrogate in the Model 3 to explore the potential impact of unmeasured confounders on the association between these IR surrogates and diabetes risk. The E-value quantifies the degree of association that unmeasured confounders would need to have with the risk of diabetes to negate the observed associations [36]. After establishing the significant associations between the four IR surrogates and diabetes, we proceeded to calculate and compare the area under the curve (AUC) for these four IR surrogates in predicting diabetes using ROC analysis and the DeLong test in both the Chinese and Japanese populations [37]. Furthermore, we conducted time-dependent ROC analysis in the Japanese population to explore the predictive performance of TyG index, TyG-BMI, TG/HDL-C ratio, and MetS-IR for future diabetes at various time intervals.

To explore whether the correlation/predictive value of the four IR surrogates with diabetes varied across different populations, we performed the same analysis steps in predefined subgroups using a multivariable Cox regression model (Model 3) and ROC analysis. All statistical analyses were conducted using R software version 3.4.3 and Empower Stats 2.0 software. Two-sided tests were used, and statistical significance was defined as P < 0.05.

Results

Baseline characteristics analysis of two cohorts

A total of 132,125 participants were included in this study, with 88.3% of the study population from the Chinese cohort and the remaining 11.7% from the Japanese cohort. The baseline characteristics of the two cohort populations were summarized in Table 1. Overall, the distribution and proportions of most baseline characteristics were comparable between the Chinese and Japanese cohorts, such as age (median age 41 vs 42), sex composition (male 53.80% vs 54.51%; female 46.20% vs 45.49%), height, ALT and HDL-C levels, and the proportion of drinkers. However, there were some differences between the two cohorts in certain measured parameters and biochemical indicators. It can be observed that, compared to the Japanese population, the Chinese population generally had higher weight and BMI, higher baseline levels of SBP, DBP, TG, AST, and the four IR surrogates, and relatively lower levels of FPG, TC, and LDL-C.

Table 1 Characteristics regarding the study variables at baseline in two cohort studies

Standardized HRs for the associations between the four IR surrogates and diabetes

In the two independent cohorts, the average follow-up time was 3.1 years (maximum 7.56 years) in the Chinese cohort, with 2681 incident cases (2.30%) of diabetes recorded, and 6.13 years (maximum 13.14 years) in the Japanese cohort, with 373 incident cases (2.41%) of diabetes recorded.

In the screening for collinearity between the four IR surrogates and baseline variables (Additional file 1: Tables S1–4), we identified that weight, BMI, TC, TG, and drinking status were collinear and were not included in the subsequent multivariable models. Furthermore, the Kaplan–Meier curve analysis, incorporating follow-up time and exposure variables, indicated that the Cox proportional hazards models constructed to assess the associations between the four IR surrogates and diabetes were appropriate for this study (Additional file 1: Figures S1–4).

The results of univariate Cox regression analysis indicated that, except for drinking status, all other baseline indicators were significantly associated with the risk of diabetes. Among them, having a smoking habit and higher levels of age, height, weight, BMI, SBP, DBP, FPG, TC, TG, LDL-C, ALT, AST were significantly associated with an increased risk of diabetes. Conversely, higher levels of HDL-C and being female were associated with a lower risk of diabetes (Additional file 1: Table S5). Subsequently, the independent associations between the IR surrogates and diabetes were demonstrated in three sequentially adjusted multivariable Cox regression models (Table 2). Consistent with the majority of previous findings, after adjusting for potential confounders, all four IR surrogates showed a significant positive association with diabetes. Based on the standardized HRs, TyG-BMI and MetS-IR exhibited the strongest associations with diabetes among the four IR surrogates (Model 3, HR: TyG-index 1.33 vs TyG-BMI 1.51 vs TG/HDL-C ratio 1.37 vs MetS-IR 1.51). Furthermore, after stratifying by ethnicity, this stronger association was still observed in the Chinese population (Model 3, HR: TyG-index 1.33 vs TyG-BMI 1.48 vs TG/HDL-C ratio 1.37 vs MetS-IR 1.47) and the Japanese population (Model 3, HR: TyG-index 1.23 vs TyG-BMI 1.79 vs TG/HDL-C ratio 1.26 vs MetS-IR 1.86). These findings suggested that both TyG-BMI and MetS-IR may be more useful in assessing the risk of diabetes, whether in the Chinese or Japanese population.

Table 2 Cox regression analyses for the association between TyG index, TyG-BMI, TG/HDL-C ratio, MetS-IR and incident DM in different models

Furthermore, to validate the stability of the aforementioned association analysis results, we calculated the E-values for each IR surrogate based on Model 3. In the All cohort, the E-values for TyG index, TyG-BMI, TG/HDL-C ratio, and MetS-IR were 1.99, 2.39, 2.08, and 2.39, respectively. Upon further differentiation by ethnicity, in the Chinese population, the E-values for TyG index, TyG-BMI, TG/HDL-C ratio, and MetS-IR were 1.99, 2.32, 2.08, and 2.3, respectively; in the Japanese population, the E-values for TyG index, TyG-BMI, TG/HDL-C ratio, and MetS-IR were 1.76, 2.98, 1.83, and 3.12, respectively. We observed that the E-values for these IR surrogates were all relatively large and higher than the corresponding HR values, indicating that it is unlikely that unmeasured confounders were affecting the stability of the results.

Association analysis of the four IR surrogates with diabetes in predefined subgroups

In predefined subgroups representing common phenotypes, we further explored the associations between the four IR surrogates and diabetes in the Chinese and Japanese populations. Detailed results were shown in Table 3. Across all subgroups, a consistent finding was observed: TyG-BMI and MetS-IR had the highest associations with diabetes among the four IR surrogates, which aligned with the results obtained from the overall population analysis and the analysis stratified by ethnicity (Table 2). This finding further supported the notion that TyG-BMI and MetS-IR may be the strongest IR surrogates for assessing the risk of diabetes.

Table 3 Stratified association between TyG index, TyG-BMI, TG/HDL-C ratio, MetS-IR and diabetes by age, BMI, sex, and hypertension

ROC analysis to evaluate the predictive value of the four IR surrogates for diabetes

Table 4 presents the AUC values of the four IR surrogates for predicting diabetes. It can be observed that in the overall population (Fig. 2), TyG-BMI had the highest AUC value for predicting diabetes compared with other IR surrogates (0.7707, all DeLong test P < 0.05), followed by MetS-IR (0.7596), TyG-index (0.7589), and TG/HDL-C ratio (0.7021). After stratifying by ethnicity, we found that in the Chinese population, TyG-BMI had the highest AUC value (0.7741, all DeLong test P < 0.05), while in the Japanese population, although TyG-BMI and MetS-IR had relatively higher AUC values (0.7738 and 0.7796) (Fig. 3), after performing the DeLong test for comparison, we found that they were only significantly higher than TG/HDL-C ratio, with no statistically significant difference from TyG index.

Table 4 Predictive value of four IR surrogates for the diabetes
Fig. 2
figure 2

ROC curve for predicting diabetes using TyG index, TyG-BMI, TG/HDL-C ratio, MetS-IR. TyG index the triglyceride-glucose index, TyG-BMI triglyceride glucose-body mass index, TG/HDL-C ratio triglyceride/high-density lipoprotein cholesterol ratio, METS-IR metabolic score for insulin resistance

Fig. 3
figure 3

ROC curves for predicting diabetes using TyG index, TyG-BMI, TG/HDL-C ratio, MetS-IR in Chinese cohort and Japanese cohort. TyG index the triglyceride-glucose index, TyG-BMI triglyceride glucose-body mass index, TG/HDL-C ratio triglyceride/high-density lipoprotein cholesterol ratio, METS-IR metabolic score for insulin resistance

Analysis of the predictive value of the four IR surrogates for diabetes in predefined subgroups

To evaluate whether the predictive value of the four IR surrogates for diabetes varied across different populations, we further conducted ROC analysis in predefined subgroups. Detailed results are presented in Table 5. Overall, consistent with the findings from the stratification by ethnicity in Table 4, we observed similar patterns in the ROC analysis of the subgroups. In the Chinese cohort, TyG-BMI demonstrated the best predictive value for diabetes in almost all subgroups, with statistically significant differences observed in the majority of AUC values after conducting the DeLong test for comparison; while in the Japanese cohort, MetS-IR had the highest AUC values for predicting diabetes in all subgroups, followed by TyG-BMI. However, the differences between the two were statistically insignificant in almost all subgroups, and only in the male subgroup, obese subgroup, age < 50 years subgroup, and no hypertension subgroup, both MetS-IR and TyG-BMI exhibited significantly higher AUC values than TyG index and TG/HDL-C ratio. Additionally, in both cohorts, the predictive accuracy for predicting diabetes was higher in females compared to males, in non-obese individuals compared to obese individuals, in younger individuals (Age < 50 years) compared to older individuals (Age ≥ 50 years), and in individuals with normal baseline blood pressure compared to those with hypertension.

Table 5 The best threshold, sensitivities, specificities, and area under the curve of four IR surrogates for predicting diabetes in different subgroups

Time-dependent ROC analysis of IR surrogates for prediction of future diabetes

To further compare the predictive abilities of TyG index, TyG-BMI, TG/HDL-C ratio, and MetS-IR for future diabetes at different time intervals, we conducted time-dependent ROC analysis in the Japanese population and presented the results in Additional file 1: Table S6. By comparing the AUC values of the four IR surrogates for predicting diabetes occurrence over 1–13 years, we found that MetS-IR had the highest AUC values at almost all time points, and TyG index and TyG-BMI exhibited similar predictive abilities, while TG/HDL-C ratio had relatively weaker predictive ability, consistent with the previous analyses. Therefore, in the Japanese population, MetS-IR may be a better surrogate marker for diabetes prediction.

Discussion

In this analysis of two diabetes cohort studies based in China and Japan, four IR surrogates, TyG index, TyG-BMI, TG/HDL-C ratio, and MetS-IR, were positively associated with diabetes. After standardizing for HRs, TyG-BMI and MetS-IR showed stronger associations with diabetes among the four IR surrogates. These stronger associations remained consistent when further stratifying by age, sex, hypertension, and BMI subgroups. Additionally, the ROC analysis of the four IR surrogates in the Chinese population showed that TyG-BMI had the highest accuracy for predicting diabetes, while in the Japanese population, both TyG-BMI and MetS-IR showed the highest predictive accuracy.

Previous studies have reported associations between individual IR surrogates and diabetes [13, 17,18,19], but few have systematically compared the value of different IR surrogates in assessing diabetes risk. To date, only a few studies from China have reported differences in the assessment of diabetes risk using IR surrogates, with some analyzing them as original continuous variables and others as categorical variables [19, 38,39,40]. Notably, two published comparative studies by Li et al. and Dong et al. utilized the China Health and Retirement Longitudinal Study for analysis. Li et al. investigated the association between quartiles of TyG index, TyG-BMI, TG/HDL-C ratio, and diabetes [19], while Dong et al. evaluated the continuous variables of TyG index, TG/HDL-C ratio, and MetS-IR in relation to diabetes [38]. Both studies found positive associations between IR surrogates and diabetes. However, due to differences in data processing, comparing the HRs of different IR surrogates and their associations with diabetes was challenging, as the scales and magnitudes of the surrogates varied. Similar data processing approaches were employed in two other published studies in Ningxia, China, and Wuyuan, China, where the associations between the TyG index, TG/HDL-C ratio, MetS-IR, and diabetes were assessed [39, 40]. In the Ningxia study, IR surrogates were analyzed based on tertiles [39], while in the Wuyuan study, they were analyzed as original continuous variables [40]. To address the issue of comparing HRs related to diabetes for IR surrogates, the current study standardized the four IR surrogates using Z-transformation before including them in the multivariable models. The analysis of the two large independent population cohorts in this study demonstrated that the TyG index, TyG-BMI, TG/HDL-C ratio, and MetS-IR were all positively associated with diabetes in both the Chinese and Japanese populations. Among them, TyG-BMI and MetS-IR showed stronger associations with diabetes, and further subgroup analysis confirmed TyG-BMI and MetS-IR as the best IR surrogates for assessing the risk of diabetes. Considering that this study standardized and compared the four IR surrogates in two large independent cohorts and consistently found TyG-BMI and MetS-IR to be the best markers for assessing diabetes risk, the results can be considered relatively reliable.

The question of which IR surrogate is most valuable for predicting diabetes has been explored in recent studies based on Chinese populations, but there is currently no consensus. Some studies supported TyG-BMI as the superior IR surrogate [19, 41], while others supported the TyG index [38, 40, 42]; for example, the study by Mo Z and colleagues found a strong correlation between the TyG index and gestational diabetes (OR = 12.923), and it demonstrated high predictive performance for future occurrences of gestational diabetes (AUC = 0.807) [42]. It should be noted that the published studies included no more than three IR surrogates, and none of them simultaneously compared the predictive value of the TyG index, TyG-BMI, TG/HDL-C ratio, and MetS-IR for diabetes. In the present study, we simultaneously assessed the predictive value of the TyG index, TyG-BMI, TG/HDL-C ratio, and MetS-IR for diabetes in two independent cohorts. The new analysis results indicated that TyG-BMI was the most accurate IR surrogate marker for predicting diabetes in the Chinese population, while in the Japanese population, both TyG-BMI and MetS-IR exhibited the highest predictive accuracy. These findings were consistent with some observations in other metabolic disease studies, including hypertension, hypertension combined with hyperuricemia, and coronary artery disease [43,44,45]. These findings collectively suggested that TyG-BMI and MetS-IR may serve as better predictors of metabolic-related diseases and should be considered in further research.

The subgroup analyses based on age, sex, hypertension, and BMI were noteworthy and worth emphasizing, as the results of these analyses were highly consistent with the main analysis, despite accounting for racial differences. These subgroup findings further supported the stability and reliability of the main results of this study, indicating that TyG-BMI and MetS-IR were likely to be the most useful IR surrogates in assessing diabetes risk; while TyG-BMI was recommended for the prediction of diabetic events in the Chinese population, MetS-IR and TyG-BMI were recommended for the Japanese population. Furthermore, based on subgroup ROC analysis we identified specific populations that were more suitable for the prediction of diabetic events using IR surrogates, including females, non-obese individuals, those under 50 years of age, and those with normal baseline blood pressure. The reasons behind these specific phenomena currently lack an answer, but they can be partially explained from a risk factor perspective. Generally, male gender, obesity, hypertension, and advanced age are important risk factors for diabetes [30, 46,47,48,49]. These confounding factors may additionally affect the accuracy of IR surrogates in predicting diabetes. In relatively lower-risk populations such as females, non-obese individuals, younger age groups, and those with normal blood pressure, the potential confounding effects are reduced, making IR surrogates a more significant risk factor for diabetes. Consequently, reaching the respective threshold values of IR surrogates may have higher predictive significance for diabetes in these populations.

Strengths and limitations

Current research has several advantages: (i) This study is the first to simultaneously evaluate and compare the predictive value and risk assessment ability of several IR surrogates for diabetes, including the TyG index, TyG-BMI, TG/HDL-C ratio, and MetS-IR. (ii) IR surrogates are combinations of commonly used clinical markers that are easily accessible and computationally straightforward. The evidence from this study provided valuable reference material for diabetes prevention and clinical practice. (iii) This study is based on two large independent cohorts, and the results obtained from both cohorts were highly consistent. The high stability of these results was further confirmed through subgroup analysis, which added to the reliability of the study's conclusions.

There are some limitations that need to be mentioned: (i) The study population is derived from China and Japan, and the results may be more applicable to East Asian populations. Further research is needed to assess the generalizability of these findings to other regions. (ii) The diabetes cohorts in China and Japan did not include measurements of postprandial glucose levels, which may result in an underestimation of the true diabetes incidence. However, despite the lower disease prevalence, the study consistently obtained highly consistent findings in different populations and subgroups, which may indicate the robustness of the current results. Moreover, measuring postprandial glucose levels may not be necessary for routine medical examinations in large epidemiological surveys. (iii) The study did not differentiate between types of diabetes. Further investigation of the applicability of IR surrogates for type 1 and type 2 diabetes could enhance the quality of the current research. However, based on the integration of published data [50, 51], the evidence from the current study was likely more suitable for the prediction and risk assessment of type 2 diabetes. (iv) The current study, being a post hoc analysis based on publicly available data, faced limitations in the study database that prevented the further assessment of factors such as the use of glucocorticoids, estrogen, thiazide-type drugs, and beta-blockers among the participants, as well as their dietary habits and physical activity. Consequently, there may be some residual confounding [52]. As an alternative approach, we calculated the E-values for the IR surrogates to assess the potential impact of confounding factors on the findings of the current study. More rigorous study designs are needed in the future to further validate our findings.

Conclusion

In this analysis of two large cohort studies in China and Japan, strong associations between TyG index, TyG-BMI, TG/HDL-C ratio, and MetS-IR with diabetes were observed, with TyG-BMI and MetS-IR showing the highest correlations with diabetes. These findings were further validated through subgroup analysis. Additionally, in terms of diabetes prediction, TyG-BMI exhibited the highest predictive value in the Chinese population, while both TyG-BMI and MetS-IR showed the highest predictive value in the Japanese population.

Availability of data and materials

The data used in this study have been uploaded to the "Dryad" database (Chinese cohort: https://doi.org/https://doi.org/10.5061/dryad.ft8750v; Japanese cohort: https://doi.org/https://doi.org/10.5061/dryad.8q0p192).

Abbreviations

IR:

Insulin resistance

TyG index:

The triglyceride-glucose index

TyG-BMI:

Triglyceride glucose-body mass index

TG/HDL-C ratio:

Triglyceride/high-density lipoprotein cholesterol ratio

MetS-IR:

Metabolic score for insulin resistance

HIEC:

Hyperinsulinemic-euglycemic clamp

TG:

Triglyceride

FPG:

Fasting plasma glucose

BMI:

Body mass index

HR:

Hazard ratio

CI:

Confidence interval

AUC:

Area under the curve

ROC:

Receiver operating characteristic curve

S/DBP:

Systolic/diastolic blood pressure

TC:

Total cholesterol

TG:

Triglyceride

LDL-C:

Low-density lipid cholesterol

ALT:

Alanine aminotransferase

AST:

Aspartate aminotransferase

SD:

Standard deviation

References

  1. Goldberg RB, Orchard TJ, Crandall JP, Boyko EJ, Budoff M, Dabelea D, et al. Effects of long-term metformin and lifestyle interventions on cardiovascular events in the diabetes prevention program and its outcome study. Circulation. 2022;145:1632–41. https://doi.org/10.1161/CIRCULATIONAHA.121.056756.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Yu M, Zhan X, Yang Z, Huang Y. Measuring the global, regional, and national burden of type 2 diabetes and the attributable risk factors in all 194 countries. J Diabetes. 2021;13:613–39. https://doi.org/10.1111/1753-0407.13159.

    Article  PubMed  Google Scholar 

  3. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–1544. https://doi.org/10.1016/S0140-6736(16)31012-1. Erratum in: Lancet. 2017;389(10064):e1.

    Article  Google Scholar 

  4. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. https://doi.org/10.1016/j.diabres.2021.109119.

    Article  PubMed  Google Scholar 

  5. Reilly SM, Saltiel AR. Adapting to obesity with adipose tissue inflammation. Nat Rev Endocrinol. 2017;13:633–43. https://doi.org/10.1038/nrendo.2017.90.

    Article  CAS  PubMed  Google Scholar 

  6. Onyango AN. Cellular stresses and stress responses in the pathogenesis of insulin resistance. Oxid Med Cell Longev. 2018;2018:4321714. https://doi.org/10.1155/2018/4321714.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214–23. https://doi.org/10.1152/ajpendo.1979.237.3.E214.

    Article  CAS  PubMed  Google Scholar 

  8. Minh HV, Tien HA, Sinh CT, Thang DC, Chen CH, Tay JC, et al. Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension. J Clin Hypertens. 2021;23:529–37. https://doi.org/10.1111/jch.14155.

    Article  CAS  Google Scholar 

  9. Borai A, Livingstone C, Ferns GA. The biochemical assessment of insulin resistance. Ann Clin Biochem. 2007;44:324–42. https://doi.org/10.1258/000456307780945778.

    Article  CAS  PubMed  Google Scholar 

  10. Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3347–51. https://doi.org/10.1210/jc.2010-0288.

    Article  CAS  PubMed  Google Scholar 

  11. Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE. 2016;11: e0149731. https://doi.org/10.1371/journal.pone.0149731.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96:399–404. https://doi.org/10.1016/j.amjcard.2005.03.085.

    Article  CAS  PubMed  Google Scholar 

  13. Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178:533–44. https://doi.org/10.1530/EJE-17-0883.

    Article  CAS  PubMed  Google Scholar 

  14. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294:E15-26. https://doi.org/10.1152/ajpendo.00645.2007.

    Article  CAS  PubMed  Google Scholar 

  15. Rabasa-Lhoret R, Laville M. Mesurer l’insulinosensibilité en pratique clinique [How to measure insulin sensitivity in clinical practice?]. Diabetes Metab. 2001;27:201–8.

    CAS  PubMed  Google Scholar 

  16. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487–95. https://doi.org/10.2337/diacare.27.6.1487.

    Article  PubMed  Google Scholar 

  17. Cheng C, Liu Y, Sun X, Yin Z, Li H, Zhang M, et al. Dose-response association between the triglycerides: High-density lipoprotein cholesterol ratio and type 2 diabetes mellitus risk: the rural Chinese cohort study and meta-analysis. J Diabetes. 2019;11:183–92. https://doi.org/10.1111/1753-0407.12836.

    Article  CAS  PubMed  Google Scholar 

  18. Pranata R, Huang I, Irvan LMA, Vania R. The association between triglyceride-glucose index and the incidence of type 2 diabetes mellitus-a systematic review and dose-response meta-analysis of cohort studies. Endocrine. 2021;74:254–62. https://doi.org/10.1007/s12020-021-02780-4.

    Article  CAS  PubMed  Google Scholar 

  19. Li X, Sun M, Yang Y, Yao N, Yan S, Wang L, et al. Predictive effect of triglyceride glucose-related parameters, obesity indices, and lipid ratios for diabetes in a chinese population: a prospective cohort study. Front Endocrinol. 2022;13:862919. https://doi.org/10.3389/fendo.2022.862919.

    Article  ADS  Google Scholar 

  20. Kim JY, Lee T, Chung TH. Predictive cut-off values for the triglyceride-to-high-density lipoprotein cholesterol ratio to predict metabolic syndrome in the middle-aged Korean population. Nutr Metab Cardiovasc Dis. 2024;S0939–4753(24):00044–9. https://doi.org/10.1016/j.numecd.2024.01.023.

    Article  CAS  Google Scholar 

  21. Chen Y, Zhang XP, Yuan J, Cai B, Wang XL, Wu XL, et al. Association of body mass index and age with incident diabetes in Chinese adults: a population-based cohort study. BMJ Open. 2018;8(9): e021768. https://doi.org/10.1136/bmjopen-2018-021768.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Int J Obes. 2019;43:139–48. https://doi.org/10.1038/s41366-018-0076-3.

    Article  Google Scholar 

  23. Chen, Ying et al. Data from: Association of body mass index and age with incident diabetes in Chinese adults: a population-based cohort study, Dryad, Dataset, 2018. 10.5061/dryad.ft8750v

  24. Okamura, Takuro et al. Data from: Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study, Dryad, Dataset, 2019. 10.5061/dryad.8q0p192

  25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.

    Article  CAS  PubMed  Google Scholar 

  26. Zhou BF, Cooperative Meta-Analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults—study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15(1):83–96.

    PubMed  Google Scholar 

  27. Sasaki A, Yokote K, Naitoh T, Fujikura J, Hayashi K, Hirota Y, Joint Committee in the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, the Japan Society for the Study of Obesity, et al. Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity. Diabetol Int. 2021;13(1):1–30. https://doi.org/10.1007/s13340-021-00551-0.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Watanabe T, Tsujino I, Konno S, Ito YM, Takashina C, Sato T, et al. Association between smoking status and obesity in a nationwide survey of Japanese adults. PLoS ONE. 2016;11(3): e0148926. https://doi.org/10.1371/journal.pone.0148926.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Schoenaker DA, Jackson CA, Rowlands JV, Mishra GD. Socioeconomic position, lifestyle factors and age at natural menopause: a systematic review and meta-analyses of studies across six continents. Int J Epidemiol. 2014;43:1542–62. https://doi.org/10.1093/ije/dyu094.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Pucci G, Alcidi R, Tap L, Battista F, Mattace-Raso F, Schillaci G. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: a review of the literature. Pharmacol Res. 2017;120:34–42. https://doi.org/10.1016/j.phrs.2017.03.008.

    Article  PubMed  Google Scholar 

  31. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 international society of hypertension global hypertension practice guidelines. J Hypertens. 2020;38:982–1004. https://doi.org/10.1097/HJH.0000000000002453.

    Article  CAS  PubMed  Google Scholar 

  32. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41:S13–27. https://doi.org/10.2337/dc18-S002.

    Article  Google Scholar 

  33. Kim JH. Multicollinearity and misleading statistical results. Korean J Anesthesiol. 2019;72:558–69. https://doi.org/10.4097/kja.19087.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Gorcsan J 3rd, Oyenuga O, Habib PJ, Tanaka H, Adelstein EC, Hara H, et al. Relationship of echocardiographic dyssynchrony to long-term survival after cardiac resynchronization therapy. Circulation. 2010;122:1910–8. https://doi.org/10.1161/CIRCULATIONAHA.110.954768.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Fitchett EJA, Seale AC, Vergnano S, Sharland M, Heath PT, Saha SK, et al. Strengthening the reporting of observational studies in epidemiology for newborn infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Lancet Infect Dis. 2016;16:e202–13. https://doi.org/10.1016/S1473-3099(16)30082-2.

    Article  PubMed  Google Scholar 

  36. VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-Value. Ann Intern Med. 2017;167(4):268–74. https://doi.org/10.7326/M16-2607.

    Article  PubMed  Google Scholar 

  37. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45.

    Article  CAS  PubMed  Google Scholar 

  38. Dong J, Liu YH, Lu YK, Hu LK, Chen N, Ma LL, et al. Association between surrogate indicators of insulin resistance and risk of type 2 diabetes combined with hypertension among Chinese adults: two independent cohort studies. Nutr Metab. 2022;19:85. https://doi.org/10.1186/s12986-022-00720-1.

    Article  CAS  Google Scholar 

  39. Li X, Xue Y, Dang Y, Liu W, Wang Q, Zhao Y, et al. Association of Non-insulin-based insulin resistance indices with risk of incident prediabetes and diabetes in a chinese rural population: A 12-year prospective study. Diabetes Metab Syndr Obes. 2022;15:3809–19. https://doi.org/10.2147/DMSO.S385906.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Wang T, Yu C, Yu GT, Zhou W, Zhu LJ, Huang X, et al. Predictive effects of different insulin resistance indexes on diabetes risk in hypertensive population. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2023;2023(45):206–12. https://doi.org/10.3881/j.issn.1000-503X.15127.

    Article  Google Scholar 

  41. Wang X, Liu J, Cheng Z, Zhong Y, Chen X, Song W. Triglyceride glucose-body mass index and the risk of diabetes: a general population-based cohort study. Lipids Health Dis. 2021;20:99. https://doi.org/10.1186/s12944-021-01532-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Mo Z, Cao C, Han Y, Hu H, et al. Relationships between triglyceride-glucose index and incident gestational diabetes mellitus: a prospective cohort study of a Korean population using publicly available data. Front Public Health. 2024;12:1294588. https://doi.org/10.3389/fpubh.2024.1294588.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Cheng W, Kong F, Chen S. Comparison of the predictive value of four insulin resistance surrogates for the prevalence of hypertension: a population-based study. Diabetol Metab Syndr. 2022;14:137. https://doi.org/10.1186/s13098-022-00907-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Li Y, You A, Tomlinson B, Yue L, Zhao K, Fan H, et al. Insulin resistance surrogates predict hypertension plus hyperuricemia. J Diabetes Investig. 2021;12:2046–53. https://doi.org/10.1111/jdi.13573.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Zhang Y, Wang R, Fu X, Song H. Non-insulin-based insulin resistance indexes in predicting severity for coronary artery disease. Diabetol Metab Syndr. 2022;14:191. https://doi.org/10.1186/s13098-022-00967-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37:278–316. https://doi.org/10.1210/er.2015-1137.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Maggio CA, Pi-Sunyer FX. Obesity and type 2 diabetes. Endocrinol Metab Clin North Am. 2003;2003(32):805–22. https://doi.org/10.1016/s0889-8529(03)00071-9.

    Article  Google Scholar 

  48. Sowers JR, Levy J, Zemel MB. Hypertension and diabetes. Med Clin North Am. 1988;72:1399–414. https://doi.org/10.1016/s0025-7125(16)30714-3.

    Article  CAS  PubMed  Google Scholar 

  49. Zhu M, Liu X, Liu W, Lu Y, Cheng J, Chen Y. β cell aging and age-related diabetes. Aging (Albany NY). 2021;13:7691–706. https://doi.org/10.18632/aging.202593.

    Article  CAS  PubMed  Google Scholar 

  50. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090–101. https://doi.org/10.1056/NEJMoa0908292.

    Article  CAS  PubMed  Google Scholar 

  51. Neville SE, Boye KS, Montgomery WS, Iwamoto K, Okamura M, Hayes RP. Diabetes in Japan: a review of disease burden and approaches to treatment. Diabetes Metab Res Rev. 2009;25:705–16. https://doi.org/10.1002/dmrr.1012.

    Article  PubMed  Google Scholar 

  52. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996;312:1215–8. https://doi.org/10.1136/bmj.312.7040.1215.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank all investigators and study participants for their support and contributions to this study.

Funding

This work was supported by Natural Science Foundation of Jiangxi Province [No. 20232BAB216004 to YZ].

Author information

Authors and Affiliations

Authors

Contributions

YZ and MB-K: conceptualization. Q-SG, MB-K, RJ-Y and QL-L: writing-original draft preparation. YZ, GT-S and SH-Z: writing-reviewing and editing. Q-SG, MB-K, QL-L, and RJ-Y: formal analysis and validation. MB-K and YZ: data curation and validation. YZ: Supervision. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Maobin Kuang or Yang Zou.

Ethics declarations

Ethics approval and consent to participate

The research protocol for the Rich Healthcare Group cohort has been approved by their institutional review board. The NAGALA cohort also has obtained approval from the Murakami Memorial Hospital ethics committee. The current study was a post-hoc analysis of data from these two cohort studies, and the research protocol was approved by the Institutional Ethics Committee of the authors' institution (Ethics Committee of Jiangxi Provincial People’s Hospital). Additionally, since the research data were anonymized, the informed consent requirement for participants was waived by the Jiangxi Provincial People's Hospital Ethics Committee. The entire study process was conducted in accordance with the principles of the Helsinki Declaration and followed the guidelines for Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement (Additional file 3: Text S1).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1.

Collinearity diagnostics steps of TyG index with other covariates. Table S2. Collinearity diagnostics steps of TyG-BMI with other covariates. Table S3. Collinearity diagnostics steps of TG/HDL-C ratio with other covariates. Table S4. Collinearity diagnostics steps of MetS-IR with other covariates. Table S5. Univariate Cox regression analysis between all baseline indicators and diabetes risk. Table S6. Best threshold and areas under the time-dependent receiver operating characteristic curves for TyG index, TyG-BMI, TyG-WC, MetS-IR, TG/HDL-C ratio predicting future diabetes risk in the Japanese cohort.

Additional file 2:

Figure S1. The cumulative hazard of prediabetes among the TyG index quartiles. TyG index: the triglyceride-glucose index. Figure S2. The cumulative hazard of prediabetes among the TyG-BMI quartiles. TyG-BMI: triglyceride glucose-body mass index. Figure S3. The cumulative hazard of prediabetes among the TG/HDL-C ratio quartiles. TG/HDL-C ratio: triglyceride/high-density lipoprotein cholesterol ratio. Figure S4. The cumulative hazard of prediabetes among the MetS-IR quartiles. MetS-IR: metabolic score for insulin resistance.

Additional file 3:

STROBE_checklist_(S1 text).

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shangguan, Q., Liu, Q., Yang, R. et al. Predictive value of insulin resistance surrogates for the development of diabetes in individuals with baseline normoglycemia: findings from two independent cohort studies in China and Japan. Diabetol Metab Syndr 16, 68 (2024). https://doi.org/10.1186/s13098-024-01307-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13098-024-01307-x

Keywords